HORITA, N., V. KOBLIZEK, Marek PLUTINSKÝ, B. NOVOTNA, Karel HEJDUK and T. KANEKO. Chronic obstructive pulmonary disease prognostic score: A new index. Biomedical Papers, Olomouc: Palacky University. Olomouc: Palacky University, 2016, vol. 160, No 2, p. 211-218. ISSN 1213-8118. Available from: https://dx.doi.org/10.5507/bp.2016.030.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name Chronic obstructive pulmonary disease prognostic score: A new index
Authors HORITA, N. (203 Czech Republic), V. KOBLIZEK (203 Czech Republic), Marek PLUTINSKÝ (703 Slovakia, guarantor, belonging to the institution), B. NOVOTNA (203 Czech Republic), Karel HEJDUK (203 Czech Republic, belonging to the institution) and T. KANEKO (392 Japan).
Edition Biomedical Papers, Olomouc: Palacky University, Olomouc, Palacky University, 2016, 1213-8118.
Other information
Original language English
Type of outcome Article in a journal
Field of Study 10103 Statistics and probability
Country of publisher Czech Republic
Confidentiality degree is not subject to a state or trade secret
WWW URL
Impact factor Impact factor: 0.894
RIV identification code RIV/00216224:14110/16:00090825
Organization unit Faculty of Medicine
Doi http://dx.doi.org/10.5507/bp.2016.030
UT WoS 000379360500005
Keywords in English COPD; prognosis; dyspnea; age; spirometry; hemoglobin
Tags EL OK
Tags International impact, Reviewed
Changed by Changed by: Soňa Böhmová, učo 232884. Changed: 15/9/2016 15:11.
Abstract
Background. The evaluation of chronic obstructive pulmonary disease (COPD) has been shifting from spirometry to focus on the patients' overall health. Despite the existence of many COPD prognostic scales, there remains a large gap for improvement, in particular a scale that incorporates the current focus on overall health. Methods. We proposed a new prognostic scale (the COPD Prognostic Score) through discussion among the authors based on published studies. Validation was retrospective, using data from the National Emphysema Treatment Trial. Results. The scores ranged from 0-16, where 16 indicated the poorest prognosis. We assigned 4 points each for forced expiratory volume in one second (%predicted), the modified Medical Research Council dyspnea scale, and age; 2 points for the hemoglobin level; and one point each for decreased activity and respiratory emergency admission in the last two years. The validation cohort included 607 patients and consisted of 388 men (73.9%) and 219 women (36.1%), mean age 67 +/- 6 years and an average forced expiratory volume in one second (% predicted) of 27 +/- 7%. A one-point increase in the score was associated with increased all-cause death, with a hazard ratio of 1.28 (95%CI: 1.21-1.36. P < 0.001). The areas under the receiver operating characteristic curves for two-year and five-year all-cause death for the new scale were 0.72 and 0.66, respectively. These values were higher than those given by the body mass index, airflow obstruction, dyspnea, and exercise capacity (BODE) index and age, dyspnea, airway obstruction (ADO) index. Conclusion. The preliminary validation for a new COPD prognostic scale: the COPD Prognostic Score was developed with promising results thus far. Above mentioned 16-point score accurately predicted 2-year and 5-year all-cause mortality among subjects who suffered from severe and very severe COPD.
PrintDisplayed: 27/7/2024 18:09